Direct connections between the protein and osteoporosis have already been described: serum levels of Sclerostin were found enhanced in postmenopausal women [41] and one of the upcoming treatments for osteoporosis is the application of anti-Sclerostin-antibodies [24], [42]. Here, SOST is linked to osteoporosis.